CUE

Cue Biopharma (CUE)

About Cue Biopharma (CUE)

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

Details

Daily high

$0.33

Daily low

$0.30

Price at open

$0.31

52 Week High

$1.54

52 Week Low

$0.23

Market cap

29.2M

Dividend yield

0.00%

Volume

379,662

Avg. volume

1.4M

P/E ratio

-.70

Cue Biopharma News